(Total Views: 409)
Posted On: 02/16/2021 2:23:48 PM
Post# of 153907
Cdiddy,
I agree completely. BP has stated that the long haulers group is quite heterogeneous. The acute patients are as well (ARDS, neuro, neurovascilar, cardiomyopathy, micro amd macro emboli).
I truly hope aviptadil is successful, as leronlimab alone, regardless of 30,50,70%mortality reduction, will be insufficient.
I agree completely. BP has stated that the long haulers group is quite heterogeneous. The acute patients are as well (ARDS, neuro, neurovascilar, cardiomyopathy, micro amd macro emboli).
I truly hope aviptadil is successful, as leronlimab alone, regardless of 30,50,70%mortality reduction, will be insufficient.
(2)
(0)
